Complete Genomics (GNOM) +9.2% premarket and adding to a surge of 44% yesterday after it announced that its Long Fragment Read (LFR) technology, a new way of mapping DNA, "dramatically improves accuracy...and significantly reduces" the amount required for testing." That should make it more accessible to patients
For the latest updates on the stock market, visit,
http://daytradingstock-blog.blogspot.com/